Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Werewolf Therapeutics, Inc. (HOWL) had Return on Investments of -70.88% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.89M |
|
$-70.52M |
|
-- |
|
$1.89M |
|
$75.48M |
|
$-73.59M |
|
$3.08M |
|
$-70.52M |
|
$-70.52M |
|
$-70.52M |
|
$-70.52M |
|
$-70.52M |
|
$-70.52M |
|
$-73.59M |
|
$-71.78M |
|
43.33M |
|
43.86M |
|
$-1.63 |
|
$-1.63 |
|
| Balance Sheet Financials | |
$113.07M |
|
$6.32M |
|
$13.86M |
|
$126.93M |
|
$15.18M |
|
$26.09M |
|
$38.36M |
|
$53.54M |
|
$73.39M |
|
$73.39M |
|
$73.39M |
|
44.83M |
|
| Cash Flow Statement Financials | |
$-56.19M |
|
$-0.25M |
|
$13.08M |
|
$155.58M |
|
$112.22M |
|
$-43.36M |
|
$8.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.45 |
|
-- |
|
-- |
|
0.26 |
|
0.36 |
|
100.00% |
|
-3904.19% |
|
-3904.19% |
|
-3807.96% |
|
-3740.85% |
|
-3740.85% |
|
$-56.44M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-96.08% |
|
-96.08% |
|
-55.55% |
|
|
Return on Investments |
-70.88% |
$1.64 |
|
$-1.29 |
|
$-1.28 |
|